Market Overview

Wedbush Reiterates Outperform and PT of $18 on DexCom


Wedbush reiterated its Outperform rating on DexCom (NASDAQ: DXCM). At the same time, Wedbush left its price target on the company's stock unchanged at $18. On Wednesday, DexCom closed teh day at $14.49.

Posted-In: dexcom WedbushReiteration Analyst Ratings


Related Articles (DXCM)

View Comments and Join the Discussion!

Latest Ratings

ELMDDougherty & Co.Initiates Coverage On12.0
MRNSCantor FitzgeraldAssumes7.0
MNRLCapital One FinancialInitiates Coverage On23.0
SONVertical GroupUpgrades
UNPMorgan StanleyMaintains136.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

UPDATE: Morgan Stanley Color on Bank of America PT Decrease

Swisher Hygiene Acquires Proclean Systems, Inc.